Table 4. Predicted Hazard ratio for treatment failure occurrence and changes in prescription based on cox proportional hazard model.
| Variables | Hazard ratio | 95% confidence interval | p-value | |
|---|---|---|---|---|
| Probability of treatment failure after adding sulfonylurea or DPP-4 inhibitor to metformin monotherapy | ||||
| MS (= reference) | ||||
| MD | 0.665 | 0.470–0.942 | 0.022 | |
| Age | 0.98 | 0.970–0.993 | 0.002 | |
| HbA1c level ≥ 8% before prescription | 2.309 | 1.745–3.056 | < 0.001 | |
| Probability of changes in prescription after adding sulfonylurea or DPP-4 inhibitor to metformin monotherapy | ||||
| MS (= reference) | ||||
| MD | 0.581 | 0.440–0.767 | < 0.001 | |
| Sex (female) | 1.303 | 1.029–1.650 | 0.031 | |
| Age | 0.987 | 0.976–0.997 | 0.012 | |
MS, patients with addition of sulfonylurea to metformin monotherapy; MD, patients with addition of DPP-4 inhibitor to metformin monotherapy.